⚠ Evidence note: Direct MPN evidence on lifestyle factors is limited; this synthesis draws heavily on adjacent literature.
Hyperbaric Oxygen Therapy (environmental/oxygen intervention)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-06-03 — Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant: Early-phase trial evaluating HBOT as peri-transplant intervention in allo-HSCT for CMML, CNL, myelofibrosis, and MDS/MPN overlap, with endpoints including safety, engraftment, GVHD, neutrophil recovery, and mucositis severity (mpn-direct, trial-early; no results yet). [mpn-direct] (novelty: 4)
Open questions
Related
Contributing findings
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
03-jun-2026
novelty 4
per-area 4
strengthens